Abstract CT014: IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)

Name: Work Video:
Duration: 3 min 30 s
Christopher J. Sweeney; Silke Gillessen; Dana E. Rathkopf; Nobuaki Matsubara; Charles G. Drake; Karim Fizazi; Josep M. Piulats; Piotr J. Wysocki; Gary L. Buchschacher; Jennifer Doss; Sanjeev Mariathasan; Edward E. Kadel; Kobe Yuen; Asim Datye; Grozdana Rasuo; Darren Tayama; Patrick Williams; Thomas Powles
{'id': 'https://openalex.org/W3083447616', 'doi': 'https://doi.org/10.1158/1538-7445.am2020-ct014', 'title': 'Abstract CT014: IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)', 'display_name': 'Abstract CT014: IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)', 'publication_year': 2020, 'publication_date': '2020-08-15', 'ids': {'openalex': 'https://openalex.org/W3083447616', 'doi': 'https://doi.org/10.1158/1538-7445.am2020-ct014', 'mag': '3083447616'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2020-ct014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5002909668', 'display_name': 'Christopher J. Sweeney', 'orcid': 'https://orcid.org/0000-0002-0398-6018'}, 'institutions': [{'id': 'https://openalex.org/I4210117453', 'display_name': 'Dana-Farber Cancer Institute', 'ror': 'https://ror.org/02jzgtq86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210117453']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher J. Sweeney', 'raw_affiliation_strings': ['1Dana-Farber Cancer Institute, Boston, MA;'], 'affiliations': [{'raw_affiliation_string': '1Dana-Farber Cancer Institute, Boston, MA;', 'institution_ids': ['https://openalex.org/I4210117453']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009101766', 'display_name': 'Silke Gillessen', 'orcid': 'https://orcid.org/0000-0001-5746-6555'}, 'institutions': [{'id': 'https://openalex.org/I4210101830', 'display_name': 'Institute of Oncology Research', 'ror': 'https://ror.org/01dpyn972', 'country_code': 'CH', 'type': 'facility', 'lineage': ['https://openalex.org/I4210101830', 'https://openalex.org/I57201433']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Silke Gillessen', 'raw_affiliation_strings': ['2Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '2Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;', 'institution_ids': ['https://openalex.org/I4210101830']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002358672', 'display_name': 'Dana E. Rathkopf', 'orcid': 'https://orcid.org/0000-0002-4503-7582'}, 'institutions': [{'id': 'https://openalex.org/I39965400', 'display_name': 'Kettering University', 'ror': 'https://ror.org/03rcspa57', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I39965400']}, {'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dana Rathkopf', 'raw_affiliation_strings': ['3Memorial Sloan Kettering Cancer Center, New York, NY;'], 'affiliations': [{'raw_affiliation_string': '3Memorial Sloan Kettering Cancer Center, New York, NY;', 'institution_ids': ['https://openalex.org/I39965400', 'https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014625956', 'display_name': 'Nobuaki Matsubara', 'orcid': 'https://orcid.org/0000-0002-9203-4245'}, 'institutions': [{'id': 'https://openalex.org/I4210145079', 'display_name': 'National Cancer Center Hospital East', 'ror': 'https://ror.org/03rm3gk43', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210145079']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Nobuaki Matsubara', 'raw_affiliation_strings': ['4National Cancer Center Hospital East, Chiba, Japan;'], 'affiliations': [{'raw_affiliation_string': '4National Cancer Center Hospital East, Chiba, Japan;', 'institution_ids': ['https://openalex.org/I4210145079']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031310463', 'display_name': 'Charles G. Drake', 'orcid': 'https://orcid.org/0000-0001-9610-3677'}, 'institutions': [{'id': 'https://openalex.org/I2799503643', 'display_name': 'Columbia University Irving Medical Center', 'ror': 'https://ror.org/01esghr10', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799503643']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Charles Drake', 'raw_affiliation_strings': ['5Columbia University Irving Medical Center, New York, NY;'], 'affiliations': [{'raw_affiliation_string': '5Columbia University Irving Medical Center, New York, NY;', 'institution_ids': ['https://openalex.org/I2799503643']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007779528', 'display_name': 'Karim Fizazi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}, {'id': 'https://openalex.org/I102197404', 'display_name': 'Université Paris-Sud', 'ror': 'https://ror.org/028rypz17', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I102197404']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Karim Fizazi', 'raw_affiliation_strings': ['6Institut Gustave Roussy, University of Paris Sud, Villejuif, France;'], 'affiliations': [{'raw_affiliation_string': '6Institut Gustave Roussy, University of Paris Sud, Villejuif, France;', 'institution_ids': ['https://openalex.org/I2801843802', 'https://openalex.org/I102197404']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019869973', 'display_name': 'Josep M. Piulats', 'orcid': 'https://orcid.org/0000-0002-3606-1724'}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}, {'id': 'https://openalex.org/I4210087039', 'display_name': "Institut d'Investigació Biomédica de Bellvitge", 'ror': 'https://ror.org/0008xqs48', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I157913058', 'https://openalex.org/I2802050225', 'https://openalex.org/I4210087039', 'https://openalex.org/I4210096656', 'https://openalex.org/I4210106543', 'https://openalex.org/I4210107147', 'https://openalex.org/I4210153292', 'https://openalex.org/I4387153040', 'https://openalex.org/I71999127']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Josep M. Piulats', 'raw_affiliation_strings': ["7Institut Català d'Oncologia-IDIBELL, Barcelona, Spain;"], 'affiliations': [{'raw_affiliation_string': "7Institut Català d'Oncologia-IDIBELL, Barcelona, Spain;", 'institution_ids': ['https://openalex.org/I4210107147', 'https://openalex.org/I4210087039']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073752190', 'display_name': 'Piotr J. Wysocki', 'orcid': 'https://orcid.org/0000-0003-4003-5278'}, 'institutions': [{'id': 'https://openalex.org/I126596746', 'display_name': 'Jagiellonian University', 'ror': 'https://ror.org/03bqmcz70', 'country_code': 'PL', 'type': 'education', 'lineage': ['https://openalex.org/I126596746']}], 'countries': ['PL'], 'is_corresponding': False, 'raw_author_name': 'Piotr J. Wysocki', 'raw_affiliation_strings': ['8Department of Oncology, Jagiellonian University Medical College, Krakow, Poland;'], 'affiliations': [{'raw_affiliation_string': '8Department of Oncology, Jagiellonian University Medical College, Krakow, Poland;', 'institution_ids': ['https://openalex.org/I126596746']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042877747', 'display_name': 'Gary L. Buchschacher', 'orcid': 'https://orcid.org/0009-0000-5713-4155'}, 'institutions': [{'id': 'https://openalex.org/I4210096972', 'display_name': 'Los Angeles Medical Center', 'ror': 'https://ror.org/00spys463', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343052199', 'https://openalex.org/I4210096972']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gary L. Buchschacher', 'raw_affiliation_strings': ['9Southern California Permanente Medical Group, Los Angeles Medical Center, Los Angeles, CA;'], 'affiliations': [{'raw_affiliation_string': '9Southern California Permanente Medical Group, Los Angeles Medical Center, Los Angeles, CA;', 'institution_ids': ['https://openalex.org/I4210096972']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5079882392', 'display_name': 'Jennifer Doss', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jennifer Doss', 'raw_affiliation_strings': ['10Genentech, Inc., South San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '10Genentech, Inc., South San Francisco, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011890417', 'display_name': 'Sanjeev Mariathasan', 'orcid': 'https://orcid.org/0000-0001-5034-773X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Sanjeev Mariathasan', 'raw_affiliation_strings': ['10Genentech, Inc., South San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '10Genentech, Inc., South San Francisco, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081609371', 'display_name': 'Edward E. Kadel', 'orcid': 'https://orcid.org/0000-0003-3030-6628'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Edward E. Kadel', 'raw_affiliation_strings': ['10Genentech, Inc., South San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '10Genentech, Inc., South San Francisco, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054079906', 'display_name': 'Kobe Yuen', 'orcid': 'https://orcid.org/0000-0001-8780-341X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kobe Yuen', 'raw_affiliation_strings': ['10Genentech, Inc., South San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '10Genentech, Inc., South San Francisco, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044210627', 'display_name': 'Asim Datye', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Asim Datye', 'raw_affiliation_strings': ['11F. Hoffmann-La Roche Ltd, Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '11F. Hoffmann-La Roche Ltd, Basel, Switzerland;', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5010385892', 'display_name': 'Grozdana Rasuo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Grozdana Rasuo', 'raw_affiliation_strings': ['11F. Hoffmann-La Roche Ltd, Basel, Switzerland;'], 'affiliations': [{'raw_affiliation_string': '11F. Hoffmann-La Roche Ltd, Basel, Switzerland;', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041518689', 'display_name': 'Darren Tayama', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Darren Tayama', 'raw_affiliation_strings': ['10Genentech, Inc., South San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '10Genentech, Inc., South San Francisco, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086743431', 'display_name': 'Patrick Williams', 'orcid': 'https://orcid.org/0000-0003-4168-9433'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Patrick Williams', 'raw_affiliation_strings': ['10Genentech, Inc., South San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '10Genentech, Inc., South San Francisco, CA;', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5107886361', 'display_name': 'Thomas Powles', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I166337079', 'display_name': 'Queen Mary University of London', 'ror': 'https://ror.org/026zzn846', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I166337079']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Thomas Powles', 'raw_affiliation_strings': ['12Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '12Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.', 'institution_ids': ['https://openalex.org/I166337079']}]}], 'institution_assertions': [], 'countries_distinct_count': 7, 'institutions_distinct_count': 14, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 7.998, 'has_fulltext': False, 'cited_by_count': 58, 'citation_normalized_percentile': {'value': 0.999975, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '80', 'issue': '16_Supplement', 'first_page': 'CT014', 'last_page': 'CT014'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.9918, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9915, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9385965}, {'id': 'https://openalex.org/keywords/taxane', 'display_name': 'Taxane', 'score': 0.52924675}, {'id': 'https://openalex.org/keywords/regimen', 'display_name': 'Regimen', 'score': 0.42481765}, {'id': 'https://openalex.org/keywords/atezolizumab', 'display_name': 'Atezolizumab', 'score': 0.41583285}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9385965}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.81596357}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.6370976}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.62435794}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.53963697}, {'id': 'https://openalex.org/C2777511904', 'wikidata': 'https://www.wikidata.org/wiki/Q425227', 'display_name': 'Taxane', 'level': 4, 'score': 0.52924675}, {'id': 'https://openalex.org/C2781190966', 'wikidata': 'https://www.wikidata.org/wiki/Q420436', 'display_name': 'Docetaxel', 'level': 3, 'score': 0.49082932}, {'id': 'https://openalex.org/C2781413609', 'wikidata': 'https://www.wikidata.org/wiki/Q7308373', 'display_name': 'Regimen', 'level': 2, 'score': 0.42481765}, {'id': 'https://openalex.org/C2775949291', 'wikidata': 'https://www.wikidata.org/wiki/Q20707748', 'display_name': 'Atezolizumab', 'level': 5, 'score': 0.41583285}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.36238968}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.31482622}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.20415545}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.20298186}, {'id': 'https://openalex.org/C2780057760', 'wikidata': 'https://www.wikidata.org/wiki/Q13896859', 'display_name': 'Pembrolizumab', 'level': 4, 'score': 0.15806276}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2020-ct014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.67, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362495421', 'https://openalex.org/W2883926068', 'https://openalex.org/W2513994891', 'https://openalex.org/W2509022872', 'https://openalex.org/W2485409297', 'https://openalex.org/W2313432166', 'https://openalex.org/W2114282601', 'https://openalex.org/W2101100140', 'https://openalex.org/W2076535051', 'https://openalex.org/W2046196715'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Current': [2], 'treatments': [3], 'for': [4, 30, 76, 117, 268, 522], 'mCRPC': [5, 43, 105, 130], 'include': [6], 'the': [7, 62, 91, 219, 301, 314, 322, 346, 412, 421, 515, 519], 'androgen': [8], 'receptor': [9, 145], 'antagonist': [10, 146], 'enzalutamide': [11, 499, 501], '(enza).': [12], 'Enza': [13], 'may': [14, 440], 'enhance': [15], 'IFNγ': [16], 'signaling': [17], 'and': [18, 66, 93, 111, 139, 191, 207, 211, 224, 250, 270, 306, 328, 333, 369, 380, 382, 388, 432, 437, 529], 'sensitize': [19], 'tumor': [20], 'cells': [21], 'to': [22, 156, 217, 235], 'immune-mediated': [23], 'cell': [24], 'killing,': [25], 'making': [26], 'it': [27], 'a': [28, 45, 55, 83, 118, 149], 'candidate': [29], 'combinations': [31], 'with': [32, 42, 48, 74, 78, 104, 275, 321, 342, 345, 374, 420, 498, 505], 'PD-L1/PD-1': [33, 46], 'inhibitors.': [34], 'Responses': [35], 'have': [36], 'been': [37], 'observed': [38, 278, 366, 415], 'in': [39, 72, 102, 300, 313, 367, 378, 386, 503], 'patients': [40, 504], '(pts)': [41], 'receiving': [44], 'inhibitor': [47], 'or': [49, 113, 131, 143, 170, 242], 'without': [50], 'enza.': [51], 'Therefore,': [52], 'atezolizumab': [53, 497], '(atezo),': [54], 'humanized': [56], 'anti-PD-L1': [57], 'monoclonal': [58], 'antibody': [59], 'that': [60], 'inhibits': [61], 'interaction': [63], 'between': [64, 221, 256, 279], 'PD-L1': [65], 'its': [67], 'receptors,': [68], 'is': [69], 'being': [70], 'examined': [71], 'combination': [73, 394], 'enza': [75, 98, 100, 165, 171, 238, 243, 304, 315, 359, 398, 406], 'pts': [77, 103, 128, 152, 232, 351], 'mCRPC.': [79], 'Methods:': [80], 'IMbassador250': [81], 'was': [82, 124, 196, 264, 293], 'Phase': [84], 'III,': [85], 'randomized': [86, 154, 234], 'clinical': [87, 251], 'trial': [88, 495], '(NCT03016312)': [89], 'evaluating': [90], 'safety': [92, 150, 416, 423], 'efficacy': [94, 260, 269], 'of': [95, 184, 188, 230, 262, 326, 371, 390, 395, 411, 425, 429, 514, 518], 'atezo': [96, 158, 236, 302, 396], '+': [97, 164, 237, 303, 356, 397], 'vs': [99, 405, 500], 'alone': [101, 244, 502], 'who': [106], 'had': [107, 129, 352], 'progressed': [108], 'on': [109], 'abiraterone': [110], 'docetaxel,': [112], 'were': [114, 153, 179, 233, 253, 319, 340, 365, 418], 'not': [115, 125, 400], 'candidates': [116], 'taxane': [119, 181], 'regimen': [120], '(androgen': [121], 'deprivation': [122], 'therapy': [123], 'given).': [126], 'Eligible': [127], 'locally': [132], 'advanced,': [133], 'incurable': [134], 'CRPC,': [135], 'ECOG': [136], 'PS': [137], '0/1': [138], 'no': [140, 276], 'prior': [141, 180], 'immunotherapy': [142], 'enza/androgen': [144], 'treatment.': [147, 427], 'After': [148], 'run-in,': [151], '1:1': [155], 'receive': [157], '1200': [159], 'mg': [160, 167, 173], 'every': [161], '3': [162], 'weeks': [163], '160': [166, 172], 'once': [168, 174], 'daily': [169, 175], 'only.': [176], 'Stratification': [177], 'factors': [178], 'treatment,': [182], 'presence': [183], 'liver': [185], 'metastases,': [186], 'level': [187], 'circulating': [189], 'LDH': [190], 'pain.': [192], 'The': [193, 258, 393, 414], 'primary': [194, 259, 323], 'endpoint': [195, 261], 'OS;': [197], 'secondary': [198, 327, 430], 'endpoints': [199, 330], 'included': [200], 'PSA': [201], 'response': [202, 439], 'rate,': [203], 'radiographic': [204], 'PFS,': [205], 'ORR': [206], 'safety.': [208], 'Tumor': [209], 'tissue': [210], 'disease': [212], 'progression': [213], 'will': [214, 334], 'be': [215, 335], 'used': [216], 'assess': [218], 'relationship': [220], 'exploratory': [222, 329, 433], 'biomarkers': [223], 'treatment': [225, 347, 438], 'response.': [226], 'Results:': [227], 'A': [228, 492], 'total': [229], '759': [231], '(n': [239, 245], '=': [240, 246, 289], '379)': [241], '380).': [247], 'Baseline': [248], 'demographic': [249], 'characteristics': [252], 'generally': [254], 'similar': [255], 'groups.': [257], 'OS': [263, 292, 403], 'evaluated': [265], '(data': [266], 'cutoff': [267], 'safety,': [271], 'June': [272], '24,': [273], '2019),': [274], 'difference': [277], 'groups': [280], '(stratified': [281], 'HR,': [282], '1.12': [283], '[95%': [284], 'CI:': [285, 297, 310], '0.91,': [286], '1.37];': [287], 'P': [288], '0.28).': [290], 'Median': [291], '15.2': [294], 'months': [295, 308], '(95%': [296, 309], '14.0,': [298], '17.0)': [299], 'group': [305], '16.6': [307], '14.7,': [311], '18.4)': [312], 'group.': [316], 'Subgroup': [317], 'analyses': [318], 'consistent': [320, 341, 419], 'endpoint.': [324], 'Analyses': [325, 428], 'are': [331], 'ongoing': [332], 'presented.': [336], 'Adverse': [337], 'events': [338], '(AEs)': [339], 'those': [343], 'seen': [344], 'components.': [348], 'Nearly': [349], 'all': [350], 'an': [353, 402], 'AE': [354], '(atezo': [355], 'enza,': [357], '96.5%;': [358], 'alone,': [360, 407], '91.8%).': [361], 'Treatment-related': [362], 'AEs': [363], '(TRAEs)': [364], '77.8%': [368], '51.1%': [370], 'pts,': [372], 'respectively,': [373], 'Grade': [375, 383], '3-4': [376], 'TRAEs': [377, 385], '28.3%': [379], '9.6%': [381], '5': [384], '1.9%': [387], '0.3%': [389], 'pts.': [391], 'Conclusions:': [392], 'did': [399], 'show': [401], 'improvement': [404], 'requiring': [408], 'early': [409], 'termination': [410], 'study.': [413], 'profiles': [417, 424], 'known': [422], 'each': [426], 'outcomes': [431], 'endpoints,': [434], 'biomarker': [435], 'studies': [436], 'provide': [441], 'further': [442], 'insight': [443], 'into': [444], 'these': [445], 'findings.': [446], 'Citation': [447], 'Format:': [448], 'Christopher': [449], 'J.': [450, 466], 'Sweeney,': [451], 'Silke': [452], 'Gillessen,': [453], 'Dana': [454], 'Rathkopf,': [455], 'Nobuaki': [456], 'Matsubara,': [457], 'Charles': [458], 'Drake,': [459], 'Karim': [460], 'Fizazi,': [461], 'Josep': [462], 'M.': [463], 'Piulats,': [464], 'Piotr': [465], 'Wysocki,': [467], 'Gary': [468], 'L.': [469], 'Buchschacher': [470], 'Jr,': [471], 'Jennifer': [472], 'Doss,': [473], 'Sanjeev': [474], 'Mariathasan,': [475], 'Edward': [476], 'E.': [477], 'Kadel,': [478], 'Kobe': [479], 'Yuen,': [480], 'Asim': [481], 'Datye,': [482], 'Grozdana': [483], 'Rasuo,': [484], 'Darren': [485], 'Tayama,': [486], 'Patrick': [487], 'Williams,': [488], 'Thomas': [489], 'Powles.': [490], 'IMbassador250:': [491], 'phase': [493], 'III': [494], 'comparing': [496], 'metastatic': [506], 'castration-resistant': [507], 'prostate': [508], 'cancer': [509], '(mCRPC)': [510], '[abstract].': [511], 'In:': [512], 'Proceedings': [513], 'Annual': [516], 'Meeting': [517], 'American': [520], 'Association': [521], 'Cancer': [523, 535], 'Research': [524], '2020;': [525], '2020': [526], 'Apr': [527], '27-28': [528], 'Jun': [530], '22-24.': [531], 'Philadelphia': [532], '(PA):': [533], 'AACR;': [534], 'Res': [536], '2020;80(16': [537], 'Suppl):Abstract': [538], 'nr': [539], 'CT014.': [540]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3083447616', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 6}, {'year': 2022, 'cited_by_count': 12}, {'year': 2021, 'cited_by_count': 25}, {'year': 2020, 'cited_by_count': 13}], 'updated_date': '2025-01-12T13:04:20.755889', 'created_date': '2020-09-11'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
